Caribou Biosciences (CRBU) Equity Ratio: 2020-2025
Historic Equity Ratio for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to 0.73.
- Caribou Biosciences' Equity Ratio fell 10.92% to 0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73, marking a year-over-year decrease of 10.92%. This contributed to the annual value of 0.81 for FY2024, which is 5.28% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Equity Ratio is 0.73, which was down 3.27% from 0.75 recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' Equity Ratio ranged from a high of 0.88 in Q4 2021 and a low of -0.30 during Q2 2021.
- In the last 3 years, Caribou Biosciences' Equity Ratio had a median value of 0.81 in 2024 and averaged 0.81.
- As far as peak fluctuations go, Caribou Biosciences' Equity Ratio skyrocketed by 374.21% in 2022, and later dropped by 10.92% in 2025.
- Over the past 5 years, Caribou Biosciences' Equity Ratio (Quarterly) stood at 0.88 in 2021, then fell by 8.18% to 0.80 in 2022, then climbed by 5.89% to 0.85 in 2023, then dropped by 5.28% to 0.81 in 2024, then fell by 10.92% to 0.73 in 2025.
- Its Equity Ratio was 0.73 in Q3 2025, compared to 0.75 in Q2 2025 and 0.79 in Q1 2025.